MedTrace Logo

Multi-center Assessment of Grafts in Coronaries: Long-term Evaluation of the C-Port Device

NCT01478061 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 115

Last updated 2015-07-22

No results posted yet for this study

Summary

The Study plan is a post-market prospective, multi-center, open-label registry. The vein graft failure rates for the currently commercialized C-Port devices will be compared to an a priori rate taken from the peer-reviewed literature.

Conditions

Interventions

DEVICE

Anastomosis (C-Port® )

creation of anastomoses in blood vessels and grafts, including use in coronary artery bypass grafting procedures

Sponsors & Collaborators

  • Cardica, Inc

    lead INDUSTRY

Principal Investigators

  • Husam Balkhy, MD · Wisconsin Heart Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2013-01-31
Completion
2015-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01478061 on ClinicalTrials.gov